Skip to Main Content

Browse issues

Volume 61, Issue 10, 15 November 2015

NEWS

Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages i–ii, https://doi.org/10.1093/cid/civ853

IN THE LITERATURE

Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages iii–iv, https://doi.org/10.1093/cid/civ854

ARTICLES AND COMMENTARIES

Glen B. Taksler and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1495–1503, https://doi.org/10.1093/cid/civ630

Adjusted odds of illnesses related to influenza were up to 21% lower for elderly individuals residing in areas with higher vaccination coverage among nonelderly adults. Findings were robust to numerous sensitivity analyses and tests for unobserved confounding.

Najaaraq Lund and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1504–1511, https://doi.org/10.1093/cid/civ617

Neonates were randomized to oral polio vaccine (OPV) and followed for mortality. Among those enrolled within the first 2 days, OPV was associated with a 42% (10%–62%) reduction in infant infectious disease mortality. OPV at birth may provide nonspecific protection against infections.

Lawrence D. Frenkel
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1512–1513, https://doi.org/10.1093/cid/civ619
Mark Campbell and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1514–1520, https://doi.org/10.1093/cid/civ642

Coccidioidal tenosynovitis of the hand and wrist is a manifestation of dissemination. Treatment requires surgical debridement plus long-term antifungal therapy against Coccidioides species. Discontinuation of antifungals can be complicated by infection relapse, requiring additional surgical debridements and reinstitution of antifungals.

Christelle Kassis and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1521–1526, https://doi.org/10.1093/cid/civ585

Coccidioidal meningitis is a common cause of chronic meningitis in endemic areas, and diagnosis is difficult and challenging. The purpose of this study was to assess the diagnostic utility of cerebrospinal fluid Coccidioides antigen detection for diagnosing coccidioidal meningitis.

Ashish A. Deshmukh and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1527–1535, https://doi.org/10.1093/cid/civ628

Treatment for high-grade anal intraepithelial neoplasia followed by quadrivalent human papillomavirus vaccination in older human immunodeficiency virus-positive men who have sex with men decreases lifetime cost and increases quality-adjusted life expectancy. Results from ongoing clinical trials will not change our policy conclusion.

Yi-Ju Tseng and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1536–1542, https://doi.org/10.1093/cid/civ636

We report on the incidence and patterns of extended use of antibiotics in patients evaluated for Lyme disease. The use of extended treatment is increasing, and a relatively few providers treat a substantial portion of the patients.

Nelli S. Lakis and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1543–1548, https://doi.org/10.1093/cid/civ643

Description of a challenging case history and treatment of a previously unknown poxvirus rash illness in a renal transplant patient and characterization of the virus, including its genome.

BRIEF REPORTS

Christiane Gaudreau and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1549–1552, https://doi.org/10.1093/cid/civ570

PHOTO QUIZ

Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page 1553, https://doi.org/10.1093/cid/civ546

INVITED ARTICLES

HEALTHCARE EPIDEMIOLOGY

Omar Lateef and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1554–1557, https://doi.org/10.1093/cid/civ510

The Chicago Ebola Response Network, a hospital and public health collaboration, was formed in response to the 2014–2015 Ebola virus epidemic and is a roadmap for how a region can prepare to respond to public health emergencies.

REVIEWS OF ANTI-INFECTIVE AGENTS

Marisa H. Miceli and Carol A. Kauffman
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1558–1565, https://doi.org/10.1093/cid/civ571

Isavuconazole is a new broad-spectrum triazole agent that has been approved for the treatment of invasive aspergillosis and mucormycosis. In vitro activity, pharmacological attributes, drug–drug interactions, adverse effects, and clinical efficacy are reviewed.

HIV/AIDS

Kristine M. Erlandson and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1566–1572, https://doi.org/10.1093/cid/civ554

The impact of statins on insulin resistance or diabetes in human immunodeficiency virus–infected persons has not been assessed within a randomized controlled study. We demonstrated that rosuvastatin led to significant worsening of insulin resistance but not clinical diabetes.

Marla J. Keller and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1573–1581, https://doi.org/10.1093/cid/civ569

Human immunodeficiency virus-infected women with a normal Pap result who nonetheless test positive for human papillomavirus (HPV) type 16 have a high risk of cervical precancer that may warrant immediate colposcopy, whereas those positive for other oncogenic HPV types are at moderate risk.

Angela Colbers and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1582–1589, https://doi.org/10.1093/cid/civ587

Maraviroc pharmacokinetics in HIV-infected women during pregnancy and post partum were determined in the P1026 and PANNA studies. Maraviroc exposure during pregnancy was approximately 30% decreased. Trough concentrations exceeded the target. The standard adult dose seems sufficient in pregnancy.

Colleen F. Kelley and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1590–1597, https://doi.org/10.1093/cid/civ664

The pre-exposure prophylaxis (PrEP) care continuum is described and applied to a cohort of Atlanta men who have sex with men (MSM) to demonstrate significant barriers to achieving protection from human immunodeficiency virus (HIV) with PrEP. Novel models of PrEP delivery are needed for MSM at high risk of HIV acquisition.

Kenneth H. Mayer and Douglas S. Krakower
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1598–1600, https://doi.org/10.1093/cid/civ665
Jonathan E. Volk and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1601–1603, https://doi.org/10.1093/cid/civ778
Kimberly A. Koester and Robert M. Grant
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1604–1605, https://doi.org/10.1093/cid/civ783
Annelot F. Schoffelen and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1606–1614, https://doi.org/10.1093/cid/civ586

In a study group of >900 human immunodeficiency virus (HIV)–infected, mainly female individuals in rural South Africa, carotid intima media thickness values are relatively high and subclinical atherosclerosis is associated with traditional cardiovascular risk factors rather than HIV-related factors.

Kirsten Alexandra Eberhardt and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1615–1623, https://doi.org/10.1093/cid/civ577

Helicobacter pylori coinfection is associated with decreased T-cell activation in antiretroviral therapy–naive human immunodeficiency virus (HIV)–positive but also in HIV-negative individuals. This finding might, in part, explain the observed association of H. pylori infection with favorable parameters of HIV disease progression.

ANSWER TO THE PHOTO QUIZ

Ioanna Argyri and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1624–1625, https://doi.org/10.1093/cid/civ550

CORRESPONDENCE

Brian S. Schwartz and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1626–1627, https://doi.org/10.1093/cid/civ640
Emmanuel Sagui and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1627–1628, https://doi.org/10.1093/cid/civ606
Núria Prim and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1628–1629, https://doi.org/10.1093/cid/civ645
Hamed Ebrahimzadeh Leylabadlo and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1629–1630, https://doi.org/10.1093/cid/civ646
Pontus Naucler and Andreas Berge
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page 1630, https://doi.org/10.1093/cid/civ634
Bharath Raj Palraj and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1630–1631, https://doi.org/10.1093/cid/civ635
Vivian Tien and others
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1631–1632, https://doi.org/10.1093/cid/civ639
Julian Torre-Cisneros and Jose Maria Aguado
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page 1632, https://doi.org/10.1093/cid/civ641
Yukari C. Manabe and Richard D. Moore
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Pages 1632–1634, https://doi.org/10.1093/cid/civ559

ERRATA

Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page 1635, https://doi.org/10.1093/cid/civ820
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page 1635, https://doi.org/10.1093/cid/civ800

COVER/STANDING MATERIAL

Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu1043
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu995
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu1019
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu1091
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu1067
Clinical Infectious Diseases, Volume 61, Issue 10, 15 November 2015, Page NP, https://doi.org/10.1093/cid/ciu1115
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close